Literature DB >> 31325064

Cardiac involvement in idiopathic inflammatory myopathies detected by cardiac magnetic resonance imaging.

Thomas Khoo1, Michael B Stokes2,3, Karen Teo2,3, Susanna Proudman4,5, Sajini Basnayake6, Prashanthan Sanders2,3, Vidya Limaye4,5.   

Abstract

Cardiac involvement in idiopathic inflammatory myopathies (IIM) adversely affects prognosis but is commonly sub-clinical. Cardiac magnetic resonance imaging (CMR) is an effective imaging modality for detecting myocardial inflammation and fibrosis but its use as a screening tool for cardiac disease in IIM has not been fully explored. Nineteen patients with IIM without cardiac symptoms underwent CMR using a specific cardiomyopathy protocol including specific sequences detecting focal and diffuse myocardial fibrosis. 9/19 patients demonstrated late gadolinium enhancement (LGE (3/9 right ventricular insertion, 1/9 sub-endocardial, 7/9 mid-wall/sub-epicardial)). T1 mapping was performed in 15 patients. In total, 7/15 had elevated native T1 values, of which four had detected LGE. Myocardial fibrosis was frequently detected in IIM patients without cardiac history. Detection of LGE and elevated T1 values may have negative prognostic implications. Longitudinal studies determining whether early or augmented treatment has a role in patients with sub-clinical cardiac involvement are needed.Key Points• Cardiac involvement in myositis adversely affects prognosis.• Cardiac magnetic resonance imaging is an effective tool for detecting cardiac involvement.• T1 mapping is a technique which detects diffuse myocardial inflammation and fibrosis.• In our study, focal and diffuse myocardial fibrosis was frequently found in myositis patients without cardiac symptoms.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Cardiomyopathy; Heart failure; Idiopathic inflammatory myopathy; Myocardial fibrosis; Myocarditis

Mesh:

Year:  2019        PMID: 31325064     DOI: 10.1007/s10067-019-04678-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.

Authors:  Vidya S Limaye; Sue Lester; Peter Blumbergs; Peter J Roberts-Thomson
Journal:  Int J Rheum Dis       Date:  2010-05       Impact factor: 2.454

Review 2.  The history of cardiovascular magnetic resonance.

Authors:  Gerald M Pohost
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

Review 3.  Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

Authors:  Sophie I Mavrogeni; George D Kitas; Theodoros Dimitroulas; Petros P Sfikakis; Philip Seo; Sherine Gabriel; Amit R Patel; Luna Gargani; Stefano Bombardieri; Marco Matucci-Cerinic; Massimo Lombardi; Alessia Pepe; Anthony H Aletras; Genovefa Kolovou; Tomasz Miszalski; Piet van Riel; AnneGrete Semb; Miguel Angel Gonzalez-Gay; Patrick Dessein; George Karpouzas; Valentina Puntmann; Eike Nagel; Konstantinos Bratis; Georgia Karabela; Efthymios Stavropoulos; Gikas Katsifis; Loukia Koutsogeorgopoulou; Albert van Rossum; Frank Rademakers; Gerald Pohost; Joao A C Lima
Journal:  Int J Cardiol       Date:  2016-04-27       Impact factor: 4.164

Review 4.  Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging.

Authors:  Sophie Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Genovefa Kolovou; George D Kitas
Journal:  Inflamm Allergy Drug Targets       Date:  2014

Review 5.  Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review.

Authors:  Raghav Gupta; Siddharth A Wayangankar; Ira N Targoff; Thomas A Hennebry
Journal:  Int J Cardiol       Date:  2010-09-09       Impact factor: 4.164

6.  Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography.

Authors:  Angela Rosenbohm; Dominik Buckert; Nora Gerischer; Thomas Walcher; Jan Kassubek; Wolfgang Rottbauer; Albert C Ludolph; Peter Bernhardt
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

7.  Acute myocarditis: noninvasive evaluation with cardiac MRI and transthoracic echocardiography.

Authors:  Orly Goitein; Shlomi Matetzky; Roy Beinart; Elio Di Segni; Hanoch Hod; Ariel Bentancur; Eli Konen
Journal:  AJR Am J Roentgenol       Date:  2009-01       Impact factor: 3.959

8.  Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases.

Authors:  Katalin Dankó; Andrea Ponyi; Tamás Constantin; Gábor Borgulya; Gyula Szegedi
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889

9.  Use of cardiac MR imaging to evaluate the presence of myocarditis in autoimmune myositis: three cases.

Authors:  Catherine Toong; Rajesh Puranik; Stephen Adelstein
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

10.  Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.

Authors:  Pauli Pöyhönen; Sari Kivistö; Miia Holmström; Helena Hänninen
Journal:  BMC Cardiovasc Disord       Date:  2014-08-27       Impact factor: 2.298

View more
  3 in total

1.  Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies.

Authors:  Yingxian Liu; Ligang Fang; Wei Chen; Yanlin Zhu; Xue Lin; Yining Wang; Xiao Li; Qian Wang; Zhenyu Liu
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

2.  Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies.

Authors:  Xue Ma; Li Xu; Yue Li; Bitao Bu
Journal:  BMC Cardiovasc Disord       Date:  2021-02-12       Impact factor: 2.298

3.  Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study.

Authors:  Andrea Péter; Ágnes Balogh; Zoltán Csanádi; Katalin Dankó; Zoltan Griger
Journal:  Arthritis Res Ther       Date:  2022-09-10       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.